It has been reported that cisplatin resistance of human ovarian cancer is related to activation of PI3K/Akt and ERK1/2 signaling pathways [15]–[16], we then determined the potential involvement of these two pathways in cisplatin and doxycycline effects on ovarian cancer cell proliferation. This evidence concerns the gene MAPK3 and ovarian cancer.